Life Science Leader Chief Editor Blog Header image Life Science Leader Chief Editor Blog Header image

Can China Be Trusted?
Can China Be Trusted? Rob Wright discusses China’s history of intellectual property (IP) theft, and wonders if the government-sponsored 10-year initiative, Made in China 2025 (MIC 2025), could exacerbate the problem.  Continue Reading...
The Future Of Biopharma — Netherlands Style
The Future Of Biopharma — Netherlands Style Rob Wright shares what he looks forward to learning about during an upcoming press tour of the Netherlands, beyond the fact that the European Medicines Agency (EMA) will be relocating there in 2019.  Continue Reading...
What Mylan Could Learn About Accountability
What Mylan Could Learn About Accountability Mylan’s inability to adequately supply its EpiPen during the 2018 back-to-school time is the latest example of corporate leadership lacking accountability.  Continue Reading...
Are Genetically Modified Organisms (GMO) A Blessing Or A Curse?
Are Genetically Modified Organisms (GMO) A Blessing Or A Curse? A question about GMOs submitted to our editorial board leads us to look more closely into this issue and how it affects the pharma industry.  Continue Reading...
Why A Biopharma Executive Founded A Game-Changing Conference
Why A Biopharma Executive Founded A Game-Changing Conference Amir Kalali, M.D., former global head of Quintiles (now IQVIA) neuroscience center of excellence, provides insight on why he decided to found an educational conference, The CNS Summit, while still working as a biopharmaceutical industry executive.  Continue Reading...
Is It Possible For A Biopharmaceutical Executive To Transcend Their Industry?
Is It Possible For A Biopharmaceutical Executive To Transcend Their Industry? What current biopharma leaders have the potential to “transcend” beyond this industry? Chief Editor Rob Wright gives his top three choices.  Continue Reading...
Are You Up To Speed On AI Terminology?
Are You Up To Speed On AI Terminology? A primer on AI terminology for the upcoming August feature with Sanofi’s Medical Function EVP, Ameet Nathwani, M.D.  Continue Reading...
The Drug Pricing Dilemma, Pfizer, And President Trump
The Drug Pricing Dilemma, Pfizer, And President Trump An op-ed regarding Pfizer’s drug-pricing actions, President Trump, and the potential impact on the biopharmaceutical industry’s image.  Continue Reading...
At The End Of The Day — And Other Phrases That Could Be Used Less
At The End Of The Day — And Other Phrases That Could Be Used Less A review of buzzwords and phrases that should be used less in the world of business.  Continue Reading...
Did BIO 2018 Do More Than Make History In Boston?
Did BIO 2018 Do More Than Make History In Boston? BIO 2018 does more than make business meeting history, but facilitates personal connections that can lead toward doing better business.  Continue Reading...